In 1922, a physician named D. E. Stanford Park published a short paper in The Lancet titled The Use of Colloidal Gold in the Treatment of Neurasthenia, Alcoholism and the Morphia Habit. The report described patients undergoing withdrawal from alcohol or morphine while receiving repeated injections of colloidal gold alongside other measures.
It is an unusual and genuinely fascinating piece of medical history. It is also easy to overinterpret.
The 1922 report does not prove that colloidal gold treats alcohol dependence, prevents withdrawal complications or improves modern alcohol recovery. It was written before randomized controlled trials became standard, involved a very small number of clinical observations, used injected colloidal gold rather than a consumer oral product, and combined gold with supervised withdrawal and other treatments.
This article looks at what Park actually reported, how the episode fits into the wider history of the nineteenth and early twentieth century “gold cures”, and what modern alcohol-treatment guidance tells us today.
Quick Answer: Did Colloidal Gold Treat Alcoholism?
A 1922 Lancet paper reported apparent improvements in several people treated with injected colloidal gold during supervised withdrawal, but this is not modern clinical evidence that colloidal gold treats alcohol use disorder.
The patients did not receive gold in isolation. Park described hypodermic colloidal-gold injections alongside bitter tonics and supervised withdrawal from alcohol or morphine. There was no randomized placebo group, blinding, standardized modern outcome measurement or long-term controlled follow-up.
The report is therefore best understood as a historical clinical observation rather than proof of efficacy.
The 1922 Lancet Report
The paper at the centre of the story was published in The Lancet in 1922:
Park DES. The Use of Colloidal Gold in the Treatment of Neurasthenia, Alcoholism and the Morphia Habit. The Lancet. 1922;199(5145):691-692.
The title itself reflects the medical language of the period. “Neurasthenia” was once used for a broad collection of symptoms such as fatigue, anxiety, poor concentration and nervous exhaustion. “Morphia habit” referred to morphine dependence.
Park described a small series of patients and attributed rapid improvements in appetite, sleep, nervous symptoms and desire for alcohol to a regimen that included colloidal gold.
View the Lancet archive record
View an archived copy via Zenodo.
What Park’s Treatment Actually Involved
The historical report is sometimes retold as though patients simply took colloidal gold and then stopped drinking. The treatment described was more complicated.
| Part of the historical regimen | What was described | Why it matters |
|---|---|---|
| Colloidal gold | Hypodermic injections, reportedly given several times a day. | Injection is not equivalent to drinking a modern colloidal-gold supplement. |
| Supervised withdrawal | Alcohol or morphine use was reduced or stopped under medical supervision. | Support and monitoring can themselves materially affect withdrawal outcomes. |
| Other preparations | Bitter tonic preparations were also used. | The effect of gold cannot be isolated from the other components. |
| Clinical observation | Park recorded apparent changes in symptoms and behaviour. | There was no randomized control group or blinded comparison. |
That distinction is central. Even if Park’s observations were recorded accurately, the design cannot tell us whether gold caused the improvements, whether supervised withdrawal and supportive care were responsible, or whether expectation, natural recovery and other factors contributed.
What the Historical Cases Reported
Park described several individuals with severe alcohol use, nervous symptoms or morphine dependence. In the article’s original case descriptions, he reported relatively rapid improvements in sleep, appetite, tremor, distress and desire for alcohol.
One case involved a 35-year-old naval commander with heavy alcohol use and severe nervous symptoms. Park reported that the patient stopped drinking within several days and later appeared to lose his desire for alcohol. Other cases included a physician using both alcohol and morphine and a business manager with alcohol use, depression and insomnia.
Those observations are historically interesting, but they should be read in the language of a physician reporting his own treatment experience rather than as independent confirmation. There was no modern diagnostic framework for alcohol use disorder, no validated withdrawal scale, no predetermined primary endpoint and no robust controlled follow-up.
The dramatic timelines therefore tell us what Park believed he observed. They do not establish a treatment effect.
Why a 1922 Case Report Is Not a Modern Clinical Trial
Clinical research standards changed enormously during the twentieth century. Today, a treatment claim for alcohol dependence would normally require carefully defined participants, standardized outcomes, safety monitoring, an appropriate comparison group and preferably randomized, blinded testing.
Park’s paper had none of those protections. It was essentially a clinician’s report of a handful of cases.
There are also two major formulation problems when people try to apply the paper to modern products:
- Route matters. Injected material and orally consumed material can have very different absorption, distribution and biological effects.
- Formulation matters. “Colloidal gold” is not one standardized substance. Particle size, concentration, surface chemistry, aggregation and manufacturing can vary between preparations.
For those reasons, the 1922 paper cannot be used as evidence that a present-day bottle of consumer colloidal gold reproduces Park’s reported effects.
The Keeley Gold Cure: A Much Bigger Historical Movement
Park’s report did not appear in a vacuum. Decades earlier, American physician Leslie E. Keeley had built an enormous addiction-treatment movement around his secret “gold cure”.
Keeley’s institutes became widely known in the late nineteenth century and treated people for alcohol and other drug dependence. The cure was heavily marketed as a medical treatment and helped popularize the idea that addiction could be approached as an illness rather than simply a moral failure.
But the exact composition of Keeley’s proprietary treatment was kept secret, and contemporary mainstream medicine was deeply sceptical. Modern historian Timothy A. Hickman has shown that Keeley’s reputation became entangled with changing professional standards, commercial medicine and debates over what counted as legitimate addiction science.
The historical importance of the Keeley movement is therefore not that it proves gold cured addiction. Its importance is that it reveals how doctors, patients and institutions were already trying to medicalize and biologically explain addiction more than a century ago.
Read Hickman’s 2018 history of the Keeley Gold Cure.
What Modern Science Says About Alcohol Dependence
Modern medicine understands alcohol dependence as a complex condition involving neuroadaptation, reward learning, stress systems, genetics, environment, physical health and psychological factors.
With repeated heavy alcohol exposure, the brain adapts to the continued presence of alcohol. Systems involving GABA, glutamate and stress signalling change over time. When a dependent person suddenly stops drinking, those adaptations can produce a hyperexcitable withdrawal state.
Symptoms can range from anxiety, sweating, insomnia and tremor to much more serious complications.
Alcohol Withdrawal Can Be Medically Dangerous
NICE guidance states that assessment should consider the severity of dependence and whether assisted withdrawal is needed. In people with severe dependence, unmanaged acute withdrawal can lead to seizures, delirium tremens and, in some cases, death.
Current evidence-based care may include medically assisted withdrawal, monitoring, psychosocial treatment and, when appropriate, medicines used either during withdrawal or to support relapse prevention.
Colloidal gold is not included in NICE recommendations for alcohol withdrawal or alcohol dependence.
Read NICE guidance on alcohol dependence and assisted withdrawal.
Is Colloidal Gold Used in Modern Alcohol Treatment?
It has no established role in modern evidence-based treatment for alcohol use disorder or alcohol withdrawal.
Historical case reports can generate hypotheses, but they are not enough to establish a treatment. The modern clinical literature and current UK treatment guidance focus on medically supervised withdrawal where required, psychological interventions, social support and established pharmacological options.
That does not make the 1922 paper meaningless. It simply changes what the paper can responsibly be used for. It is evidence that colloidal gold was historically experimented with in addiction medicine, not evidence that it should be used as an addiction treatment today.
Does Modern Gold Nanoparticle Research Revive the 1922 Idea?
Gold nanoparticles are now studied across many areas of biomedical research, including drug delivery, diagnostics, inflammation, cellular redox biology and experimental neurology.
That modern research makes Park’s historical experiment more interesting from a history-of-medicine perspective, but it does not retrospectively validate his addiction treatment.
An engineered gold nanoparticle used in a laboratory or pharmaceutical programme can differ substantially from Park’s injected colloid and from a present-day consumer colloidal-gold product. Research in one disease, cell model or formulation cannot be transferred automatically to alcohol withdrawal.
For a broader evidence map, see the Gold Nanoparticles Research Library. For the basic distinction between colloids and engineered nanomaterials, read What Is Colloidal Gold?.
How Strong Is the Evidence?
| Evidence | What it shows | What it does not show |
|---|---|---|
| Park, 1922 | A physician reported apparent improvement in several patients receiving injected colloidal gold as part of a broader withdrawal regimen. | Does not prove efficacy, isolate gold’s effect or apply directly to oral consumer colloidal gold. |
| Keeley Gold Cure history | Gold-branded addiction treatment became a large historical medical and commercial movement. | Popularity and patient testimony do not establish a pharmacological effect. |
| Modern addiction medicine | Alcohol dependence and withdrawal are now managed with structured assessment, assisted withdrawal when needed, psychological care and established medicines. | Current guidance does not establish a therapeutic role for colloidal gold. |
| Modern gold nanoparticle research | Specific engineered AuNP formulations can have measurable biological effects in experimental settings. | Does not prove that colloidal gold treats alcohol dependence or withdrawal. |
What This Forgotten Report Can Still Teach Us
The most interesting lesson from Park’s paper is not that a forgotten cure has been rediscovered. It is that physicians were already experimenting with finely dispersed gold and thinking biologically about addiction long before modern neuroscience, standardized addiction medicine or nanotechnology existed.
The report also illustrates why medical evidence standards matter. A clinician can observe a striking recovery and still be unable to determine which part of a complex treatment caused it.
Seen this way, the 1922 paper belongs in the history of gold medicine and the history of addiction treatment. It is a compelling historical source, but it should not be turned into a modern therapeutic claim.
Frequently Asked Questions
Was colloidal gold really published in The Lancet as an alcoholism treatment?
Yes. D. E. Stanford Park published a short 1922 paper in The Lancet titled The Use of Colloidal Gold in the Treatment of Neurasthenia, Alcoholism and the Morphia Habit. It described a small number of clinical cases.
Did the 1922 paper prove colloidal gold works for alcohol dependence?
No. The report was an uncontrolled series of clinical observations. Patients received injected colloidal gold alongside supervised withdrawal and other preparations, so the effect of gold could not be isolated.
Was the historical colloidal gold taken orally?
Park described hypodermic injections. That route is materially different from drinking a modern colloidal-gold product, so the historical report cannot be transferred directly to oral supplements.
What was the Keeley Gold Cure?
Leslie Keeley operated a famous late nineteenth century network of addiction-treatment institutes built around a proprietary “gold cure”. The movement was historically influential but also controversial because the formula was secret and its efficacy was disputed.
Is colloidal gold recommended for alcohol withdrawal today?
No. Current UK guidance does not recommend colloidal gold for alcohol withdrawal or alcohol dependence. Treatment is based on assessment, assisted withdrawal when needed, psychological support and established medicines.
Can stopping alcohol suddenly be dangerous?
Yes, for people with moderate or severe dependence. Acute withdrawal can include seizures, delirium tremens and other serious complications. Anyone concerned about alcohol dependence or withdrawal should seek appropriate medical assessment rather than relying on a supplement or attempting an unsafe abrupt detox.
References and Historical Sources
- Park DES. The Use of Colloidal Gold in the Treatment of Neurasthenia, Alcoholism and the Morphia Habit. The Lancet. 1922;199(5145):691-692. Lancet archive.
- Hickman TA. Keeping secrets: Leslie E. Keeley, the gold cure and the 19th-century neuroscience of addiction. Addiction. 2018;113(9):1739-1749. PubMed PMID 29575499.
- National Institute for Health and Care Excellence. Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence. CG115. NICE recommendations.
